If you're like many in the medical device industry, you've probably had some questions at one time or another around the FDA's Design Control Guidance.

And if you're anything like the guests on today's podcast, you've probably gone through a lot of trial and error trying to implementing them.

Wouldn't it be nice if some industry vets were willing to sharing with you their proven best practices and top recommendations for implementing design controls at your medical device company, so you can avoid problems later?

You know, the kinds of problems that could cost you months of runway or even stop your device from being approved by the FDA altogether?

If so, today's inaugural episode of the Global Medical Device Podcast powered by greenlight.guru, is for you.

Jon Speer is a medical device expert with over 16 years industry experience who's played a part in getting 40+ devices approved by the FDA, and he is the Co-founder of greenlight.guru.

Michael Drues, Ph.D., is a prolific speaker and consultant to the medical device industry as well as being the President of Vascular Sciences.

Join in to hear Dr. Drues and Mr. Speer share some perspectives, opinions, and experiences about various interesting aspects of Design Controls for the medical device industry, including the classic discussion about "research" versus "development" and when should Design Controls begin?

They'll also cover a range of topics including:

- How do larger companies take on acquisitions when there is little to no Design Control documentation?

- Examples of how to manage up-classification situations, i.e., class I à class II or III and addressing Design Controls

- When should Design Controls begin?

- When to make the transition from "R" to "D"

Buckle in, these guys really know their stuff about medical device product development and the nuances Design Controls can present.